Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Apply
Enfortumab Vedotin & Pembrolizumab
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step